[Eli Lilly and Company](https://www.lillyinvestigatorresearch.com)

June 15, 2026 (Application due date / full proposal submission)

Funding amount not specified; support may include study drug and/or financial support as determined per proposal and final agreement.

Investigator-initiated research support for real-world effectiveness of mirkizumab in IBD and disease-state epidemiology in overweight/obese individuals with IBD in Canada.

--- ## Description This opportunity from Eli Lilly and Company invites Canadian researchers to submit investigator-initiated proposals focused on two main objectives: (1) evaluating the real-world effectiveness of mirkizumab in treating inflammatory bowel disease (IBD), and (2) studying the epidemiology of disease states in overweight and/or obese individuals living with IBD in Canada. The initiative aims to generate evidence specific to the Canadian context to inform clinical effectiveness and epidemiological understanding for these populations. The grantee is fully responsible for the design, conduct, and regulatory aspects of the study. --- ## Due Dates - **Application Due Date:** June 15, 2026 Submit completed proposal form via email to CCRG@lilly.com. --- ## Funding Amount - **Funding Details:** The specific funding amount is not published. Support may include provision of study drug and/or financial support, as determined in the final agreement based on the submitted proposal's scope and budget. - **Award Duration:** Not specified; determined by the proposed study timeline. --- ## Eligibility - Open to researchers and institutions based in Canada. - Proposals must be for external, investigator-initiated, designed, and sponsored studies. - The investigator/institution is responsible for: - Study design and conduct - Regulatory sponsorship and compliance - The research must address one or both of the following: - Real-world effectiveness of mirkizumab in IBD - Epidemiology of disease states in overweight and/or obese individuals with IBD in Canada --- ## Application Process 1. **Review the RFP**: Visit the [Lilly Investigator Research competitive grants page](https://www.lillyinvestigatorresearch.com/competitive-grants) and locate the relevant RFP to download the full RFP PDF for detailed requirements. 2. **Download the Proposal Form**: Obtain the proposal form from the same RFP page. 3. **Prepare Proposal**: Complete the proposal form following the RFP and form instructions. Ensure all required Canadian context, regulatory, and methodological details are included. 4. **Submit Proposal**: Email the completed proposal form to [CCRG@lilly.com](mailto:CCRG@lilly.com) on or before June 15, 2026. 5. **Review Process**: Proposals are reviewed by global Lilly medical and scientific staff, with possible input from an external review committee. Final decisions are based on alignment with program objectives and scientific merit. --- ## Additional Information - Only investigator-initiated research is eligible; Lilly will not be involved in the study design or execution. - All proposals must be submitted at least 60 days before the intended program start date; earlier submission is recommended for international applicants. - Results and outcomes from funded research should not be commercialized but should be made publicly accessible. - Full eligibility, design guidance, and data requirements are detailed in the official RFP PDF. --- ## External Links - [Lilly Investigator Research – Competitive Grants](https://www.lillyinvestigatorresearch.com/competitive-grants) - [Lilly Investigator Research – Submit a Concept](https://www.lillyinvestigatorresearch.com/) - [Lilly Grant Office – FAQ](https://grantoffice.lilly.com/faq) - [Lilly Grant Office – Requirements](https://grantoffice.lilly.com/requirements) --- ## Contact Information | Contact Type | Details | |--------------|---------| | Email (Proposal Submission) | [CCRG@lilly.com](mailto:CCRG@lilly.com) | | General Inquiries | [Lilly Investigator Research Contact Page](https://www.lillyinvestigatorresearch.com/contact-us) | | Grant Office Support | [Lilly Grant Office FAQ](https://grantoffice.lilly.com/faq) | ---

Request for Proposals in Canada: Real-world Effectiveness of Mirkizumab in IBD and Disease-state Epidemiology in Overweight and/or Obese Individuals Living With IBD in Canada

Sign in to see full grant listing